Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population

Familial Cancer

Volumn 9, Issue 4, 2010, Pages 519-523

  Negura, Lucian ^a   Uhrhammer, Nancy ^b   Negura, Anca ^c   Artenie, Vlad ^c   Carasevici, Eugen ^a   Bignon, Yves Jean ^b  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b CENTRE JEAN PERRIN   (France)

^c ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

BRCA genes; Breast ovarian cancer predisposition; HBOC families; Mutations; North Eastern Romania; Unclassified variants

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; OVARY CANCER; PRIORITY JOURNAL; ROMANIA; TUMOR SUPPRESSOR GENE;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MASS SCREENING; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; ROMANIA;

EID: 78650216597     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9361-6     Document Type: Article

References (32)

1. Ferlay J et al (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. International Agency for Research on Cancer Press (IARC Cancer base no.5) - IARC Press, Lyon. Available at http://apps.who.int/ bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=76&codcch= 12#
2. MC King JH Marks JB Mandell for The New York BreastCancer Study Group 2003 Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 Science 302 643 646 1:CAS:528:DC%2BD3sXotlWqt7Y%3D 10.1126/science.1088759 14576434 (Pubitemid 37310920)
3. WHOSIS-World Health Organization Statistical Information System ( http://www.who.int/whosis/en/ )
4. Romanian Cancer League ( http://www.romaniancancerleague.org/en/index.php )
5. CC Sun PT Ramirez DC Bodurka 2007 Quality of Life for patients with epithelial ovarian cancer Nat Clin Pract Oncol 4 1 18 29 10.1038/ncponc0693 17183353 (Pubitemid 46017691)
6. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding, et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 1:CAS:528:DyaK2MXhtF2ns70%3D 10.1126/science.7545954 7545954 (Pubitemid 24345325)
7. R Wooster SL Neuhausen J Mangion Y Quirk D Ford N Collins K Nguyen S Seal T Tran D Averill, et al. 1994 Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 265 5181 2088 2090 1:CAS:528:DyaK2cXmsFejsLY%3D 10.1126/science.8091231 8091231 (Pubitemid 24325690)
8. SA Narod 2002 Modifiers of risk of hereditary breast and ovarian cancer Nature Rev Cancer 2 2 113 123 10.1038/nrc726 (Pubitemid 37328798)
9. DF Easton JL Hopper DC Thomas A Antoniou PDP Pharoah A Whittemore RW Haile 2004 Breast cancer risks for BRCA1/2 carriers Science 306 2187 2188 1:CAS:528:DC%2BD2cXhtFGnsL7I 10.1126/science.306.5705.2187c 15622557
10. D Ford DF Easton J Peto 1995 Estimates of the gene frequency of BRCA1 mutations and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1457 1462 1:CAS:528:DyaK28XktFSisw%3D%3D 8533776
11. A Antoniou, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130 1:CAS:528:DC%2BD3sXjslagtbg%3D 10.1086/375033 12677558 (Pubitemid 36530000)
12. JL Bermejo K Hemminiki 2006 Risks of cancer and families J Natl Cancer Inst 98 8 563 564 10.1093/jnci/djj138 16622128 (Pubitemid 43898823)
13. A Chetrit, et al. 2008 Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer J Clin Oncol 26 1 9 10 10.1200/JCO.2007.11.6905
14. N Uhrhammer S Bornes Y-J Bignon 2005 Quelle place tiennent les gènes BRCA1 et BRCA2 dans les risques héréditaires de cancer de l'ovaire? Oncologie 7 526 530 1:CAS:528:DC%2BD2sXhtVemu7jI 10.1007/s10269-005-0283-0 (Pubitemid 43074502)
15. E Honrado J Benitez J Palacios 2005 The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications Mod Pathol 18 10 1305 1320 1:CAS:528:DC%2BD2MXhtVWiu7fP 10.1038/modpathol.3800453 15933754 (Pubitemid 41348649)
16. Breast Information Core (BIC) database ( http://research.nhgri.nih.gov/ bic/ )
17. T Walsh S Casadei KH Coats E Swisher SM Stray J Higgins KC Roach J Mandell MK Lee S Ciernikova L Foretova P Soucek MC King 2006 Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 12 1379 1388 1:CAS:528:DC%2BD28Xislehurs%3D 10.1001/jama.295.12. 1379 16551709
18. P Chan B Wong H Ozcelik D Cole 1999 Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR Clin Chem 45 8 1285 1287 1:CAS:528:DyaK1MXltFGms7Y%3D 10430798 (Pubitemid 29424271)
19. Human Genome Variation Society (HGVS) Nomenclature for the description of sequence variations ( http://www.genomic.unimelb.edu.au/mdi/mutnomen/ )
20. B Gorski, et al. 2000 Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer Am J Hum Genet 66 1963 1968 1:CAS:528:DC%2BD3cXntV2ju7w%3D 10.1086/302922 10788334 (Pubitemid 30480103)
21. E Grzybowska, et al. 2002 Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population Acta Biochim Pol 49 2 351 356 1:CAS:528:DC%2BD38XlsFCrtbc%3D 12362976 (Pubitemid 135686781)
22. H Janiszewska, et al. 2003 Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujavy region of Poland Clin Genet 64 502 508 1:STN:280:DC%2BD2c%2Fps1Ortg%3D%3D 10.1046/j.1399-0004.2003.00178.x 14986830 (Pubitemid 37493121)
23. RB Bar-Sade, et al. 1998 The 185delAG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazi Hum Mol Gen 7 5 801 805 1:CAS:528:DyaK1cXjsVaktLo%3D 10.1093/hmg/7.5.801 9536083 (Pubitemid 28221242)
24. MG Fitzgerald, et al. 1996 Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer N Engl J Med 334 3 143 149 1:CAS:528:DyaK28Xos1GlsA%3D%3D 10.1056/NEJM199601183340302 8531968 (Pubitemid 26017951)
25. S Ciernikova, et al. 2006 Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families Neoplasma 53 2 97 102 1:CAS:528:DC%2BD28XjslOhs7s%3D 16575464
26. A Jasinska, et al. 2000 Prevalence of BRCA1 founder mutations in Western Poland Hum Mutat 389 1 7
27. O Ozsurek, et al. 2001 Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families Clin Genet 60 470 471 10.1034/j.1399-0004.2001.600611.x (Pubitemid 34083264)
28. AN Loginova, et al. 2003 Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families Bull Exp Biol Med 136 3 276 278 1:CAS:528:DC%2BD3sXpvVGnsLY%3D 10.1023/B:BEBM.0000008982. 21806.9b 14666193 (Pubitemid 38443438)
29. M Van der Looij, et al. 2000 Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary Int J Cancer 86 5 737 740 1:CAS:528:DC%2BD3cXjslSlsbo%3D 10.1002/(SICI)1097-0215(20000601)86: 5<737::AID-IJC21>3.0.CO;2-1 10797299 (Pubitemid 30249888)
30. A Kataki, et al. 2005 Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals-correlation with clinicopathological data Clin Genet 67 322 329 1:STN:280:DC%2BD2M7gtlajug%3D%3D 10.1111/j.1399-0004.2004.00400.x 15733268 (Pubitemid 40424828)
31. H Yazici, et al. 2000 BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients Br J Cancer 83 6 737 742 1:CAS:528:DC%2BD3cXntFOhs7o%3D 10.1054/bjoc.2000.1332 10952777
32. F Eisinger, et al. 2004 Identification and management of hereditary predisposition to cancer of the breast and the ovary Bull Cancer 91 3 219 237 15171047 (Pubitemid 38534706)